INTRODUCTION
Attention-deficit hyperactivity disorder (ADHD) is a clinically heterogeneous disorder with an onset in infancy characterized by the presence of three principal symptoms" hyperactivity, inattention, and impulsivity (Oades, 1998) . Results from neuropsychological and neuroimaging studies suggest that abnormalities of the prefrontal cortex coexist with a dysfunction of subcortical areas that project to the prefrontal cortex, leading to the definition of 'frontosubcortical alteration', an expression that reflects the complexity of this disorder and answers questions on the site of the defect that causes ADHD (see Faraone & Biederman, 2002, for review) . The treatment of ADHD is represented by drugs that raise the synaptic concentration of dopamine and norepinephrine through different mechanisms. Although the first line of treatment is represented by psychostimulants like methylphenidate and dextroamphetamine (Whalen et al., 1989; Solanto, 1998) , tricyclic antidepressants can be used while weighing the risks and benefits because of their moderate to strong side effects. Anti- depressants that can be used in ADHD therapy are drugs like imipramine, desipramine, clomipramine, nortriptiline, and amytriptiline that block the reuptake of norepinephrine and serotonin (Wilens et al., 1995; Spencer et al., 2002; Pliszka, 2003) , but not the selective serotonin reuptake inhibitor (SSRI) (B iederman et al., 1997) .
The increase of catecholamine transmission, either at the level of the basal ganglia or at the level of the prefrontal cortex, might be the key to the medication potential of psychostimulants and antidepressants. The study of synaptosomes, slices, vesicles, and cells in culture has contributed to elucidating the mechanism of act;.on of amphetamine and its involvement in vesicle trafficking at the catecholaminergic terminal level. This issue was recently reviewed by Schmitz et al. (2003) . The (Davids et al., 2003) . Among them, spontaneously hypertensive rats (SHR) (Yamory et al., 1984) have been widely investigated because relative to their Wistar-Kyoto (WKY) normotensive controls, SHR rats show behavioral abnormalities (hyperactivity and hyper-reactivity to stress) (Knardahl & Sagvolden, 1979 ) that resemble those of human ADHD. Moreover, when compared with WKY controls, SHR rats exhibit increased activity when exposed to different contexts (Sagvolden et al., 1992a,b) , a heightened response to stress with marked increase of plasma catecholamines (Chiueh, 1981) , altered reinforcement mechanisms (Berger & Sagvolden, 1998) , deficient sustained attention (Sagvolden, 2000) , and impaired acquisition of operant tasks (Wyss, 1992; Mook et al., 1993; Sagvolden, 2000) . Spontaneously hypertensive rats also have a reduced number of Ca2//calmodulin-dependent proteinkinase II (CaMKII) elements and a lower expression of the peptide product of the FOS family and ZIF-268 in the shell of the nucleus aceumbens (NAt) (Papa et al., 1998) . Moreover, in SHR rats, CaMKII levels can be normalized by chronic methylphenidate treatment.
In view of the evaluation of the effects of psychostimulants and norepinephrine reuptake blockers on SHR rats, we must point out that SHR rats have a greater rate of norepinephrine uptake, mediated by the norepi-nephrine transporter (NET), in the frontal cortex during early development, and that such changes are accounted for by an increased Vmax of the norepinephrine uptake mechanism (Myers et al., 1981) . Moreover, the authors detected a significant decrease in dopamine uptake in the frontal cortex and striatum of the SHR at 6 weeks of age, thus suggesting an important role for dopamine in the development of both hypertension and behavioral hyperactivity exhibited by these animals. An interesting study on the expression pattern of the specific genes involved in dopamine neuron differentiation, survival, and functioning during postnatal development of the ventral midbrain in SHR males has shown that tyrosine hydroxylase (TH) and dopamine transporter (DAT) gene expression are significantly reduced in the SHR midbrain during the first month of postnatal development (Leo et al., 2003) .
A promising new animal model of ADHD is represented by WKHA rats (Hendley & Fan, 1992; Hendley, 2000) . The Another animal model of ADHD is represented by dopamine transporter knockout mice (DAT-KO) (Giros et al., 1996) that have an elevated synaptic dopamine concentration in the striatum and the nucleus aecumbens (NAt) (Carboni et al., 2001) and show hyperactivity and learning impairment . Recently the Naples high-excitability (NHE) rat line was also proposed as an animal model of ADHD for its increased behavioral activity and impaired attention, which might be due to a hyperfunctioning of the meso-corticolimbic dopamine system (Sadile et al., 1993; Papa et al., 1995; Gonzales-Lima & Sadile, 2000) . In summary, although several animal strains may be hyperactive and show attention deficit, the SHR strain shows the highest number of behavioral symptoms resembling those observed in ADHD (Sagvolden, 2000) . (Sagvolden et al., 1992a, b (Garris & Wightman 1994; Clements 1996; Sesak et al., 1998) .
A contribution to the removal of dopamine from the extracellular space in the PFCX can also be provided by norepinephrine terminals (Carboni et al., 1990 , Yamamoto & Novotney, 1988 KO (Giros et al., 1996) and knock down (KD) (Zhuang et al., 2001 ) of the DAT gene.
Moreover, as amphetamine reduces hypermotility in DAT-KO mice, it has been suggested that DAT-KO and DAT-KD support the hyperdopaminergic hypothesis of ADHD (Solanto, 2002; Russell, 2002 (Liang & Rutledge, 1982) or by membrane diffusion, due to its lipophilic properties (Mack & Bonisch, 1979) . In the neuron terminal, amphetamine can label the vesicular monoamine transporter VMAT2 (Sulzer & Rayport, 1990) and, dissipating the pH that drives vesicular monoamine uptake (Sulzer et al., 1995) , generates the dopamine efflux (Heikkila, 1975) . Dopamine, in turn, can diffuse into the terminal cytoplasm and leave it through the inversion of the transport direction of the DAT (Sulzer et al., 1995; . Vesicular monoamine stores, therefore, can play a significant role in locomotor activity, attention, and reinforcing processes as confirmed in heterozygotic VMAT-2 KO mice, in which amphetamine produces enhanced locomotor activity but diminished behavior reward (Takahashi et al., 1997) .
A complementary hypothesis tested in chromaffin cells (Mundorf, 1999) (Stanley, 1993) .
A (Swanson & Volkow, 2002) . The drug shows a high affinity for the DAT and NET and much less tbr the serotonin transporter (SERT) (Gatley et al., 1996) . The in vivo potency of methylphenidate on the DAT in the human brain is similar to that of cocaine . Additionally, its psychopharmacological properties, evaluated in behavioral, assays are similar to those of cocaine (Gatley et al., 1999 (Gatley et al., 1996) .
This effect, in turn, might be shared by antidepressants that are currently used clinically (Pliszka, 2003 (Grace 1991 (Grace ,2001 (Middlemiss & Hutson, 1990 ).
The effect of amphetamine on neurotransmitter release in synaptosomes and vesicles has been studied widely. Amphetamine can enter into the synaptosomal preparation through a saturable active transport, as studied by the uptake of 3H-amphetamine (Zaczek et al., 1991) . Amphetamine can determine the release of previously loaded 3H-dopamine from striatal synaptosomes vesicles that share the feature of being the target of reserpine (Masuoka, 1982) . As mentioned in the previous paragraph, besides dopamine, amphetamine and related psychostimulants like 3,4-methylenedioxymethamphetamine (MDMA), (+)-methamphetamine, and ephedrine release norepinephrine more potently than they release dopamine and serotonin (Rothman et al., 2001 ). Furthermore, the authors showed that whereas the psychostimulants rank order of potency for dopamine release was similar to their rank order of potency in published self-administration studies; the oral dose of these stimulants, which produce amphetamine-type subjective effects in humans, correlate with their potency in releasing norepinephrine not dopamine. This observation can influence future research on the mechanism of action of amphetamine in relation to the therapeutic effect on ADHD.
An interesting effect of amphetamine, which might also have implications in ADHD therapy, is its action on dopamine synthesis. The stimulation of dopamine synthesis in rat brain striatal synaptosomes produced by the depolarizing agent veratridine is markedly reduced by prior in vivo amphetamine administration (Patrick et al., 1981) . On the other hand, it has been suggested that amphetamine can increase dopamine synthesis, apparently through a mechanism that depends on a functioning uptake carrier as it is prevented by uptake inhibitors like nomifensine and benztropin (Connor & Kuczenski, 1986 ).
Amphetamine increases particulate protein kinase C (PKC) activity in striatal synaptoneurosomes. The increased PKC activity is linked to the outward transport of dopamine and when the release is diminished, the inward transport of amphetamine inhibits PKC instead (Giambalvo, 2003) . It would be interesting to test this evidence in synaptoneurosomes from SHR and WKY rats to ascertain any differences that could be related to the different sensitivity of dopamine release due to amphetamine in vivo and in slices (Russell et al., 1998; Carboni et al. 2003) .
Among (Gnegy et al., 1993) . Amphetamine can also increase the phosphorylation of synapsin in rat striatal synaptosomes, which in turn can play a role in enhanced dopamine release (Iwata et al., 1997) . A last interesting observation was obtained in synpatosomes from SHR rats and from WKHA rats, a strain characterized by developing hyperactivity but not hypertension. In SHR rats, a significant increase in norepinephrine uptake, primarily through an increase in Vmax in cerebral cortical areas and the cerebellum, is associated with the hypertensive trait, whereas a significant increase in dopamine uptake Vmax in the frontal cortex is associated with the inheritance of hyperactivity among these strains (Hendley & Fan, 1992 (Russell et al., 1995 (Russell et al., , 1998 Russell, 2000 Russell, , 2002 (Russell, 2000) .
The possibility that amphetamine interacts with dopamine release triggered by high potassium was investigated in striatal synaptosomes and slices by Bowyer et al., (1987 .
Whole cell studies Some interesting insight into the mechanism of action of amphetamine was recently provided by Khoshbouei et al. (2003) . The If we now assume that in the rat neuron, specifically in NAc terminals, some of the above described mechanisms occur, then it becomes challenging to speculate that the higher amount of dopamine released by amphetamine in SHR rats than in WKY rats 
In vivo studies
Among the methods used to elucidate the mechanisms involved in the release of a neurotransmitter, microdialysis offers the advantage of evaluating the concentration of a transmitter in the dialysate, which directly reflects the extracellular concentration at the synaptic clefts. The concentration at the synaptic clefts, in turn, depends on the amount released by a firing-and calcium-dependent process and on the efficiency ofthe reuptake system in removing the transmitter from the synaptic cleft. Dopamine release from both dendrites and terminals can be assayed in vivo in unanesthetized rats using the microdialysis method (Di Chiara, 1990; Di Chiara et al., 1996; Justice, 1993; Westerink, 2000; Carboni, 2003) . The microdialysis technique, therefore, allows the evaluation of endogenous dopamine that, after being released by a depolarization/ calcium-dependent process, escapes from the synaptic clet, and reaches the microdialysis fiber to be collected in the artificial cerebrospinal fluid. Moreover, the synaptic dopamine concentration is dependent on the capturing capability of the DAT and therefore depends on the firing activity of the terminal and on the density of DAT sites in the area studied. Even in microdialysis, it is possible to study dopamine release triggered by an artificial depolarization, which can be achieved in the area surrounding the microdialysis fiber by perfusing the fiber with an artificial cerebrospinal fluid containing an elevated K + concentration.
The acute and chronic effects of amphetamine and/or methylphenidate have been widely studied by microdialysis (Carboni et al., 1989; Cadoni et al., 1995; Kuczenski et al., 1995; Carboni et al., 2003) . Cadoni et al. (1995) , investigating the role of vesicular and newly synthesized dopamine in the action of amphetamine, reported that the increase of extracellular dopamine evoked by amphetamine (0.2 and 0.5 mg/kg s.c.) in the dorsal striatum, was only parti'ally prevented by the blockade of dopamine synthesis by alpha-methylp-tyrosine pretreatment or by the inactivation of vesicular amine uptake by reserpine pretreatment. The combined treatment instead produced a dramatic reduction of the amphetamine-evoked dopamine output. Kuczenski et al. (1995) reported that both amphetamine and methylphenidate (2 mg/kg s.c.)
promote the equivalent increase of dopamine output in the caudate, whereas amphetamine is more potent in raising the synaptic concentration of norepinephrine in the hippocampus. We recently reported that the systemic administration of amphetamine (0.25 and 0.5 mg/kg s.c.) and methylphenidate (1 or 2 mg/kg i.p.) produces a higher increase in dialysate dopamine in the shell of SHR than in the shell of WKY rats. In contrast, when the microdialysis fiber was perfused with 30 or 60 mM K + through reverse dialysis, the increase of the dialysate dopamine was lower in SHR rats than in WKY rats. The results, compared and critically discussed with the results of other studies investigating the effect of amphetamine, methyl-phenidate, and high potassium depolarization, using in vitro preparations, suggest the existence of different dopamine-containing vesicle pools in the NAc shell dopamine terminals of SHR and WKY rats.
Moreover, we reported that the basal extracellular dopamine concentration in the NAc shell is higher in SHR rats than in WKY rats. On the other hand, no difference between SHR and WKY rats, in both basal and amphetamine-induced striatal dopamine release and metabolites, was found by Ferguson et al. (2003) . This result is in contrast with what we recently reported , but an explanation can be found in the different age of the rats used (6-week-old rats in our study versus 19-week-old rats in the Ferguson study) and in the brain area investigated (NAc in our study, striatum in Ferguson study).
Yu et al. (1990) found no difference between dopamine levels in the striata and NAc from 9-week-old WKY and SHR rats. In groups treated acutely with cocaine, the dopamine levels in these two brain regions were surprisingly unaffected, whereas 2 h after the administration of cocaine, both strains showed a significant increase in striatal HVA. Subacute cocaine administration in WKY and SHR, however, affected dopamine levels in the striata and NAc differently. One more study reported a positive, linear correlation between the extracellular levels of dopamine and cocaine for the 60-min period following acute cocaine administration in both SHR and WKY rats. On the other hand, the slope of the linear regression plots obtained from the data of each 15-min sample was slightly, but significantly, higher in conscious SHR than in conscious WKY (Inada et al., 1992) .
In summary, in vivo microdialysis studies have been revealed as a very useful tool for investigating the effect of amphetamine and methylphenidate in either normotensive or hypertensive rats, although the differences in the brain area investigated and in the age of the rats hamper a direct comparison of the results.
DISCUSSION
Synaptic release and consequently the extracellular concentration of dopamine measured depend on a sequence of events that begins with terminal depolarization and ends with the reuptake or the diffusion the transmitter. The higher extracellular concentration of dopamine observed in the NAc of SHR rats than in the NAc of WKY rats suggests that in SHR rats, synaptic transmission in the NAc occurs by means of a higher dopamine concentration in the synaptic clett. The elevated synaptic dopamine concentration cannot be recognized as being due to either elevated tonic or elevated phasic activity because phasic activity can be measured on a subseconds to seconds timescale (Venton et al., 2003; Grace, 1991 Grace, , 1995 Although the differences observed in NAcbasal dopamine release is of limited entity, this dissimilarity could represent a crucial transmission alteration that might be involved in the expression of the typical behavioral observed in SHR rats (Knardahl & Sagvolden, 1979) , and it is possible to speculate that children affected by ADHD might have in common with SHR rats an elevated dopamine transmission in the NAc. This view is supported by the increase in TH activity found in another animal model of ADHD, the Naples highexcitability (NHE) rat (Viggiano et al., 2000 (Viggiano et al., , 2002 (Kumai et al., 1996) and TH gene expression (Reja et al., 2002) in the medulla oblongata of SHR rats. On this basis, it has been speculated that an increased dopamine output in the NAc would be compensating for a reduced transduction mechanism (Papa et al., 1998 (Russell, 2000) that the difference between SHR and WKY rats regarding the response to amphetamine and to high K / lies at the vesicle level.
A further mechanism in which amphetamine is involved is the so called 'redistribution' of in dopamine terminals (Sandoval et al., 2001 (Sandoval et al., , 2002 Fleckenstein & Hanson, 2003 
